We report a case of super refractory status epilepticus uncontrolled by multiple anti-seizure medications in an individual with acute liver failure due to hepatic cirrhosis and an obstructive ileocecal mass plus multiple bilateral lung lesions presumed to be metastatic. A ketamine infusion was initiated late in his hospitalization which eliminated the convulsive seizures in less than an hour. The abatement of convulsive seizures allowed his grieving wife to return to her husband’s bedside to witness the withdrawal of life sustaining treatment and be present during the final 24 hours of his life. We review the medical literature on the role of Intravenous (IV) Ketamine in the treatment of super refractory status epilepticus.
BetjemannJPLowensteinDH. Status epilepticus in adults. Lancet Neurol. 2015;14(6):615-624.
2.
LogroscinoGHesdorfferDCCascinoG, et al.Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia. 2005;46(Suppl 11):46-48.
3.
KoubeissiMAlshekhleeA. In-hospital mortality of generalized convulsive status epilepticus: a large US sample. Neurology. 2007;69(9):886-893.
4.
TrinkaECockHHesdorfferD, et al.A definition and classification of status epilepticus - report of the ILAE Task force on classification of status epilepticus. Epilepsia. 2015;56(10):1515-1523. Epub 2015 Sep 4. PMID: 26336950. doi:10.1111/epi.13121.
5.
TrinkaEKälviäinenR. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017;44:65-73.
6.
RosatiADe MasiSGuerriniR. Ketamine for refractory status epilepticus: a systematic review. CNS Drugs. 2018;32(11):997-1009.
7.
BrophyGBellRClaassenJ, et al.Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3-23.
8.
Amengual-GualMSanchez FernandezIWainwrightMS. Novel drugs and early polypharmacotherapy in status epilepticus. Seizure. 2019;68:79-88.
9.
GolubDYanaiADarziKPapadopoulosJKaufmanB. Potential consequences of high-dose infusion of ketamine for refractory status epilepticus: case reports and systematic literature review. Anaesth Intensive Care. 2018;46(5):516-528.
10.
CruickshankMImamuraMCounsellC, et al.Management of the first stage of convulsive status epilepticus in adults: a systematic review of current randomized evidence. J Neurol. 2022;4:1-10.
11.
NelsonSEVarelasPN. Status epilepticus, refractory status epilepticus, and super-refractory status epilepticus. Continuum: Lifelong Learning in Neurology. 2018;24(6):1683-1707.
12.
GrönheitWPopkirovSWehnerTSchlegelUWellmerJ. Practical management of epileptic seizures and status epilepticus in adult palliative care patients. Front Neurol. 2018;9:595.
13.
PowerKNGramstadAGilhusNEEngelsenBA. Adult non-convulsive status epilepticus in a clinical setting: semiology, aetiology, treatment, and outcome. Seizure. 2015;24:102-106.
14.
LorenzlSMayerSFeddersenBJoxRNoachtarSBorasioGD. Nonconvulsive status epilepticus in palliative care patients. J Pain Sympt Mgmt. 2010;40:460-465.
15.
HoflerJRohracherAKalssG. (S)-Ketamine in refractory and super-refractory status epilepticus: a retrospective study. CNS Drugs. 2016;30:869-876.
16.
GaspardNForemanBJuddLM, et al.Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013;54(8):1498-1503.
17.
SabharwalVRamsayEMartinezR, et al.Propofol-ketamine combination therapy for effective control of super-refractory status epilepticus. Epilepsy Behav. 2015;52:264-266.
18.
HockerSEBrittonJWMandrekarJNWijdicksEFMRabinsteinAA. Predictors of outcome in refractory status epilepticus. JAMA Neurol. 2013;70:72-77.
19.
MarksSWilliamsAPeltierWHelmsACarlsonC. Treat the patient, not the test when a hospitalized patient in status epilepticus transitions to comfort-focused goals of care. J Palliat Med. 2018;21(8):1195-1198.
20.
VosslerDBainbridgeJBoggsJG, et al.Treatment of refractory convulsive status epilepticus: a comprehensive review by the American epilepsy society treatments committee. Epilepsy Curr. 2020;20(5):245-264.
21.
BorsatoGSiegelJRoseMQ, et al.Ketamine in seizure management and future pharmacogenomic considerations. Pharmacogenomics J. 2020;20:351-354.
22.
WasterlainCGChenJW. Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs. Epilepsia. 2008;49(Suppl 9):63-73.
23.
NaylorDE. Glutamate and GABA in the balance: convergent pathways sustain seizures during status epilepticus. Epilepsia. 2010;51(Suppl 3):106-109.
24.
PrommerE. Ketamine Use in Palliative Care. Fast Facts and Concepts #132. (January 2016).
25.
PrommerE. Ketamine for pain: an update of uses in palliative care. J Pall Med. 2012;15(4):474-483.
RosatiIlventoAL, Efficacy of ketamine in refractory convulsive status epilepticus in children: a protocol for a sequential design, multicenter, randomized, controlled open-label, non-profit trial (KETASER01). BMJ Open. 2016;6:e011565. Clinical Trials.com, Identifier NCT02431663. Visited 9/10/2023@
ZeilerFA. Early use of the NMDA receptor antagonist ketamine in refractory and super-refractory status epilepticus. Critical Care Research and Practice. 2015;2015:831260.
34.
IlventoLRosatiAMariniCL'ErarioMMirabileLGuerriniR. Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation. Epilepsy Behav. 2015;49:343-346.
35.
AlolayanYMcKinleyKBhatiaRAlkhachroumA. Review and updates on the treatment of refractory and super refractory status epilepticus. J Clin Med. 2021;10(14):3028. doi:10.3390/jcm10143028.
FujikawaD. Starting ketamine for neuroprotection earlier than its current use as an anesthetic/antiepileptic drug late in refractory status epilepticus. Epilepsia. 2019;60(5):373-380.
38.
KramerA. Early ketamine to treat refractory status epilepticus. Neurocrit Care. 2012;16:299-305.
39.
SynowiecASinghDSYenugadhatiVValerianoJPSchramkeCJKellyKM. Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res. 2013;105:183-188.
40.
SinghDKellyK, et al.Use of ketamine in treating refractory status epilepticus. Epilepsia (2009): 50 (Suppl.11): 63.
41.
AlkhachroumADer-NigoghossianCMathewsE, et al.Ketamine to treat super-refractory status epilepticus. Neurology. 2020;95:e2286-e2294.
42.
RosatiAIlventoL, et al.Efficacy of ketamine in refractory convulsive status epilepticus in children: a protocol for a sequential design, multicenter, randomized, controlled open-label, non-profit trial (KETASER01). BMJ Open2016;6:e011565. doi:10.1136/bmjopen-2016-011565. Clinical Trials.com, Identifier NCT02431663. Visited 9/10/2023 @. https://clinicaltrials.gov/search?term=NCT02431663
43.
SamalaRParala-MetzADavisM. Non-convulsive status epilepticus in a palliative care unit: when delirium is a seizure. Am J Hosp Palliat Care. 2015;32(2):243-247.
44.
LeeSK. Diagnosis and treatment of status epilepticus. J Epilepsy Res. 2020;10(2):45-54.
45.
KalviainenRReinikainenM. Management of prolonged epileptic seizures and status epilepticus in palliative care patients. Epilepsy Behav. 2019;101:1-6.
46.
DroneyJHallE. Status epilepticus in a hospice inpatient setting. J Pain Symp Mgmt. 2008;36(1):97-105.
47.
ShresthaGJoshiPChhetriSKarnRAcharyaSP. Intravenous ketamine for treatment of super-refractory convulsive status epilepticus with septic shock: a report of two cases. Indian J Crit Care Med. 2015;19(5):283-285.
48.
GolfMPaiceJFeulnerEO'LearyCMarcotteSMulcahyM. Refractory status epilepticus. J Palliat Med. 2004;7(1):85-88.
49.
KramerA. Early ketamine to treat refractory status epilepticus. Neurocrit Care. 2012;16:299-305.
